Literature DB >> 3396528

Malnutrition among tuberculosis patients in Harrow, England.

J K Onwubalili1.   

Abstract

Nutritional assessment was performed on 30 patients, aged 19-61 years, admitted to the Lister Unit of Northwick Park Hospital, Harrow, with active tuberculosis. Nutritional measurements were related to the duration and extent of disease, and also compared with those obtained in healthy age-, sex- and ethnic-matched controls before and during treatment of patients. Tuberculosis patients had significant reductions in body mass index (weight/height2) (P = 0.001), triceps skinfold thickness (P = 0.01), arm muscle circumference (P = 0.002), serum albumin (P less than 0.0001), iron (P less than 0.0001) and total iron binding capacity (P less than 0.001). Chemotherapy was associated with progressive nutritional recovery and restoration of nutrition-related indices. However, mean arm muscle circumference and serum albumin levels of the patients remained subnormal at 12 months, suggesting that body protein reserves may not be fully repleted during treatment. Active tuberculosis is associated with profound protein-energy undernutrition which improves during treatment. Further study is required to determine whether dietary protein supplementation may accelerate recovery from tuberculosis.

Entities:  

Mesh:

Year:  1988        PMID: 3396528

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  22 in total

Review 1.  [What should be done in weight loss of unknown origin?].

Authors:  A Schwenk
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  Serum ferroxidase albumin ratio as a marken in pulmonary tuberculosis.

Authors:  Hitender Singh Batra; Parduman Singh; Babu Lal Somani; Ashish Gupta; Sangeetha Sampath; Vivek Ambade
Journal:  Indian J Clin Biochem       Date:  2007-09

3.  Weight gain and response to treatment for multidrug-resistant tuberculosis.

Authors:  Ma Tarcela Gler; Ruffy Guilatco; Janice C Caoili; Julia Ershova; Peter Cegielski; John L Johnson
Journal:  Am J Trop Med Hyg       Date:  2013-09-09       Impact factor: 2.345

Review 4.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

5.  Tuberculosis and nutrition: disease perceptions and health seeking behavior of household contacts in the Peruvian Amazon.

Authors:  M R Baldwin; P P Yori; C Ford; D A J Moore; R H Gilman; C Vidal; E Ticona; C A Evans
Journal:  Int J Tuberc Lung Dis       Date:  2004-12       Impact factor: 2.373

6.  Evaluation of nutritional status of new tuberculosis patients at the effia-nkwanta regional hospital.

Authors:  Ea Dodor
Journal:  Ghana Med J       Date:  2008-03

7.  Pulmonary tuberculosis and drug resistance in Dhaka central jail, the largest prison in Bangladesh.

Authors:  Sayera Banu; Arman Hossain; Mohammad Khaja Mafij Uddin; Muhammad Reaj Uddin; Tahmeed Ahmed; Razia Khatun; Asif Mujtaba Mahmud; Khurshid Alam Hyder; Afzalunnessa Binte Lutfor; Md Sirajul Karim; Khalequ Zaman; Md Ashraful Islam Khan; Pravat Chandra Barua; Stephen P Luby
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

8.  Anemia in hospitalized patients with pulmonary tuberculosis.

Authors:  Marina Gribel Oliveira; Karina Neves Delogo; Hedi Marinho de Melo Gomes de Oliveira; Antonio Ruffino-Netto; Afranio Lineu Kritski; Martha Maria Oliveira
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

9.  Hypercalcemia in patients with newly diagnosed tuberculosis in Abuja, Nigeria.

Authors:  E A Dosumu; J A Momoh
Journal:  Can Respir J       Date:  2006-03       Impact factor: 2.409

10.  Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfected with HIV.

Authors:  Kidola Jeremiah; Paolo Denti; Emmanuel Chigutsa; Daniel Faurholt-Jepsen; George PrayGod; Nyagosya Range; Sandra Castel; Lubbe Wiesner; Christian Munch Hagen; Michael Christiansen; John Changalucha; Helen McIlleron; Henrik Friis; Aase Bengaard Andersen
Journal:  Antimicrob Agents Chemother       Date:  2014-04-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.